{"nct_id":"NCT05660967","title":"Subcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell Lymphoma","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-10","start_date":"2023-03-06","start_date_type":"ACTUAL","primary_completion_date":"2026-01-30","primary_completion_date_type":"ESTIMATED","completion_date":"2027-07-31","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["GMAB"]}